Disease Progression and Survival of Patients With Positive Lymph Nodes After Radical Prostatectomy. Is there a Chance of Cure?
- 1 March 2003
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 169 (3), 849-854
- https://doi.org/10.1097/01.ju.0000049032.38743.c7
Abstract
In prostate cancer involvement of regional lymph nodes is regarded as a poor prognostic factor. Is this also true for micrometastasis if a meticulous lymph node dissection is performed? We determined progression rate and survival of patients with positive nodes following radical prostatectomy according to the number of metastases.Between 1989 and 1999, 367 patients with clinically organ confined prostate cancer underwent meticulous pelvic lymph node dissection and radical prostatectomy. None of the patients received immediate adjuvant therapy.Of the patients 92 (25%) had histologically proven lymph node metastases. Followup of more than 1 year was available in 88 patients (96%), and median followup was 45 months (range 13 to 141). Of 19 patients (22%) who died of prostate cancer 16 had more than 1 positive node. Of the 39 patients with only 1 positive node 15 (39%) remained without signs of clinical or chemical progression. Whereas of the 20 and 29 patients with 2 or more positive lymph nodes only 2 (10%) and 4 (14%), respectively, remained disease-free. Time to prostate specific antigen relapse, symptomatic progression and tumor related death were significantly affected by the number of positive nodes.Meticulous lymph node dissection reveals a high rate of metastases (25%). In patients with positive nodes time to progression is significantly correlated with the number of diseased nodes. Some patients with minimal metastatic disease remain free of prostate specific antigen relapse for more than 10 years after prostatectomy without any adjuvant treatment. Meticulous pelvic lymph node dissection, particularly in patients with micrometastases, seems not only to be a staging procedure, but may also have a positive impact on disease progression and long-term disease-free survival.Keywords
This publication has 22 references indexed in Scilit:
- LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY: The 15-Year Johns Hopkins ExperienceUrologic Clinics of North America, 2001
- PELVIC LYMPH NODE METASTASES FROM BLADDER CANCER: OUTCOME IN 83 PATIENTS AFTER RADICAL CYSTECTOMY AND PELVIC LYMPHADENECTOMYJournal of Urology, 2001
- The use of sentinel lymphadenectomy to identify candidates for postoperative adjuvant therapy of melanoma and breast cancerSeminars in Oncology, 2001
- Risk of prostate carcinoma death in patients with lymph node metastasisCancer, 2001
- RADICAL RETROPUBIC PROSTATECTOMY PLUS ORCHIECTOMY VERSUS ORCHIECTOMY ALONE FOR pTxN+ PROSTATE CANCER: A MATCHED COMPARISONJournal of Urology, 1999
- Lower Incidence of Unsuspected Lymph Node Metastases in 521 Consecutive Patients with Clinically Localized Prostate CancerJournal of Urology, 1992
- Extended experience with surgical treatment of stage D1 adenocarcinoma of prostate: Significant influences of immediate adjuvant hormonal treatment (orchiectomy) on outcomeUrology, 1989
- Penile Cancer: Relation of Extent of Nodal Metastasis to SurvivalJournal of Urology, 1987
- Management of Invasive Bladder Cancer: A Meticulous Pelvic Node Dissection Can Make a DifferenceJournal of Urology, 1982
- The incidence and extent of pelvic lymph node metastases in apparently localized prostatic cancerCancer, 1981